An important advance was the recent observation that the triorganotins TBT and TPT are potent activators of the nuclear hormone receptors RXR and PPARγ and that they promote adipocyte differentiation, suggesting that these organotins might contribute to the development of metabolic diseases [24]–[27]. This evidence concerns the gene PPARG and metabolic disease.